After you receive your prescription, your doctor may file patient enrollment forms to get Benefits Investigation started on your behalf. During this process, you’ll get your first call from your Care Coordinator.

A Benefits Investigation (BI) is an important step to complete to determine the anticipated out-of-pocket cost of your medication and its administration. It will help define health plan requirements based on your benefits and individual care plan.

Once enrolled, your dedicated ONWARD Care Coordinator will work with you to understand your personal situation and explain potential financial assistance options available, even if you’re uninsured.

ONWARD™ is a personalized support experience built to help you through every step of your prescribed UCB treatment. With ONWARD, you’ll be paired with your own dedicated Care Coordinator who will provide tailored support based on your unique needs.

There are three ways to be enrolled in ONWARD:

• Ask your doctor to sign you up.
• Download a Start Form and bring it to your doctor.
• Call 1-884-ONWARD-1  (1-844-669-2731) today.

After enrolling in ONWARD, you’ll be contacted by your personal ONWARD Care Coordinator.

Care Coordinators are:

• Medically trained professionals, including nurses and pharmacists
• Professionally trained to understand your disease and treatment
• Dedicated to your treatment experience

*ONWARD Care Coordinators do not provide medical advice and will refer you to your healthcare professional for any questions related to your treatment plan. 

After you enroll, your Care Coordinator will call you directly to begin providing personalized support and resources.

You and your caregivers can reach your Care Coordinator at the number provided or 844-ONWARD-1 (844-669-2731), Monday – Friday from 8AM to 8PM ET.

A subcutaneous infusion is a way of administering medicine that is delivered under the skin; RSYTIGGO is administered to the right or left below the navel.

Live attenuated or live vaccines are not recommended during treatment with RYSTIGGO. Immunization with vaccines during RYSTIGGO treatment has not been studied.

You can also use our Infusion Center Finder. This tool makes it easy for you to locate your nearest infusion center.

You should always contact your healthcare provider immediately if a dose is missed. In most cases, RYSTIGGO may be administered up to 4 days after the scheduled time point. Thereafter, resume the original dosing schedule until the treatment cycle is completed.

The most common adverse reactions (reported in at least 10% of patients treated with RYSTIGGO in the clinical trials) were headache, infections, diarrhea, pyrexia, hypersensitivity reactions, and nausea. If you have questions about side effects associated with RYSTIGGO, you should talk to your doctor, who can give you more information.

Tracking your symptoms allows you to see how you are responding to treatment over time. By tracking and communicating your MG-ADL results to your doctor, your healthcare team can make sure you’re on the right treatment path.